Arkolith/Insider Trading/BIOA/Form 4

Goldstein Dov A MD

Chief Financial OfficerBioAge Labs, Inc. (BIOA) · full profile →Form 4 · filed Jan 15, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$532K
Net Open-Market Flow
-$532K
Transactions
6
5 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 13, 2026Sell(S)4K$19.45$86K36K
Jan 13, 2026Sell(S)12K$20.54$240K24K
Jan 13, 2026Sell(S)2K$21.08$41K22K
Jan 13, 2026Sell(S)9K$18.43$165K40K
Jan 13, 2026Option exercise(M)27K$8.39$227K49K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 13, 2026Option exercise(M)27K—$093K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001120478-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML